The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome–coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectr...
Saved in:
| Published in | The Journal of biological chemistry Vol. 295; no. 15; pp. 4773 - 4779 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
10.04.2020
American Society for Biochemistry and Molecular Biology |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome–coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome–CoV and Middle East respiratory syndrome (MERS–CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS–CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS–CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3′–5′ exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays. |
|---|---|
| AbstractList | Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome-coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position
, the inhibitor caused RNA synthesis arrest at position
+ 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3'-5' exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays. Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome–coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome–CoV and Middle East respiratory syndrome (MERS–CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS–CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS–CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3′–5′ exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays. Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome–coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome–CoV and Middle East respiratory syndrome (MERS–CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS–CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS–CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i , the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3′–5′ exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays. Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome-coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3'-5' exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays.Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome-coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3'-5' exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays. |
| Author | Gordon, Calvin J. Götte, Matthias Tchesnokov, Egor P. Feng, Joy Y. Porter, Danielle P. |
| Author_xml | – sequence: 1 givenname: Calvin J. surname: Gordon fullname: Gordon, Calvin J. organization: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada – sequence: 2 givenname: Egor P. surname: Tchesnokov fullname: Tchesnokov, Egor P. organization: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada – sequence: 3 givenname: Joy Y. surname: Feng fullname: Feng, Joy Y. organization: Gilead Sciences, Inc., Foster City, California 94404 – sequence: 4 givenname: Danielle P. surname: Porter fullname: Porter, Danielle P. organization: Gilead Sciences, Inc., Foster City, California 94404 – sequence: 5 givenname: Matthias surname: Götte fullname: Götte, Matthias email: gotte@ualberta.ca organization: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32094225$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UUuLFDEQDrLizq7ePUmOXnrMq18ehGFYH7AqyAreQjqpOFm6kzbJDPTVX27G2RUVNJeQqu-Rqu8CnfngAaGnlKwpacWL20GvN1vKyJpQTurmAVpR0vGK1_TLGVoRwmjVs7o7Rxcp3ZJyRE8foXPOSC8Yq1fo-80OsPLZHVxUI9ZhmsPeGxxhMpCOVTyHDD6PC3Z-5waXE_70YVMZmMGb0ji-CmZcJogqAbYxTPi9M2YEfKVSLlJpLuI5xAWnxZvSh2IUg1dFfp8eo4dWjQme3N2X6PPrq5vt2-r645t32811pYXguTK2ZUSAgI4REC1jA_QNqXVPbGNBCE1VO3S25m0_AB-MKkNy2_RgrWYdZfwSvTrpzvthAqPL38vIco5uUnGRQTn5Z8e7nfwaDrKlNWvrpgg8vxOI4dseUpaTSxrGUXkI-yQZbwThrO-6An32u9cvk_vFF0BzAugYUopgpXZZZReO1m6UlMhjwrIkLH8mLE8JFyL5i3iv_R_KyxMFynYPDqJM2oHXYFwEnaUJ7t_kH8KpwIo |
| CitedBy_id | crossref_primary_10_1073_pnas_2304139120 crossref_primary_10_1126_science_abn1900 crossref_primary_10_1177_2050640620920157 crossref_primary_10_1016_j_lfs_2020_118663 crossref_primary_10_1007_s12011_020_02194_9 crossref_primary_10_1016_j_jviromet_2020_113995 crossref_primary_10_2217_fmb_2021_0064 crossref_primary_10_1007_s42399_020_00360_7 crossref_primary_10_1016_j_csbj_2021_06_005 crossref_primary_10_1080_14767058_2020_1774875 crossref_primary_10_1016_j_envres_2020_110119 crossref_primary_10_1055_s_0040_1716634 crossref_primary_10_1016_j_bpj_2021_07_026 crossref_primary_10_1016_j_sjbs_2022_103481 crossref_primary_10_3389_fimmu_2020_01606 crossref_primary_10_1002_bmc_5380 crossref_primary_10_1128_CMR_00109_21 crossref_primary_10_1007_s12602_021_09833_0 crossref_primary_10_1126_science_abc1560 crossref_primary_10_1128_AAC_01155_21 crossref_primary_10_2147_DDDT_S278892 crossref_primary_10_1080_1120009X_2020_1868237 crossref_primary_10_1007_s11756_021_00792_z crossref_primary_10_1021_acsomega_4c05469 crossref_primary_10_3390_vaccines9040349 crossref_primary_10_1007_s00508_020_01734_6 crossref_primary_10_1039_D1RA06589K crossref_primary_10_1016_j_cbi_2021_109449 crossref_primary_10_3390_pathogens9050320 crossref_primary_10_1021_acs_jproteome_0c00392 crossref_primary_10_1016_j_compbiomed_2020_104156 crossref_primary_10_1080_13543776_2021_1880568 crossref_primary_10_3390_v12091023 crossref_primary_10_1007_s13337_020_00650_7 crossref_primary_10_1016_j_bcp_2021_114424 crossref_primary_10_1007_s11101_020_09720_6 crossref_primary_10_3389_fmolb_2022_999291 crossref_primary_10_3389_fphar_2020_585888 crossref_primary_10_3390_molecules25235535 crossref_primary_10_1016_j_cegh_2020_07_011 crossref_primary_10_1016_j_medntd_2021_100057 crossref_primary_10_1016_j_isci_2020_101849 crossref_primary_10_3390_molecules27061773 crossref_primary_10_3390_molecules27061894 crossref_primary_10_1080_10406638_2022_2127803 crossref_primary_10_3390_molecules27217370 crossref_primary_10_2174_1573398X16999201203162129 crossref_primary_10_1021_acsabm_3c00339 crossref_primary_10_1038_s41598_024_70003_7 crossref_primary_10_1177_2472555220963667 crossref_primary_10_3389_fphar_2020_572870 crossref_primary_10_31083_j_rcm2202041 crossref_primary_10_1016_j_isci_2021_103120 crossref_primary_10_1128_mBio_03492_20 crossref_primary_10_1016_j_drudis_2020_08_002 crossref_primary_10_3389_fphar_2020_582025 crossref_primary_10_1016_j_biocel_2021_106114 crossref_primary_10_3389_fphar_2020_561334 crossref_primary_10_2174_0115734129323940240809053530 crossref_primary_10_1007_s44179_022_00019_9 crossref_primary_10_3390_ijms251910820 crossref_primary_10_1007_s12038_020_00067_w crossref_primary_10_1074_jbc_RA120_015394 crossref_primary_10_1016_j_mayocp_2020_04_027 crossref_primary_10_2174_1568026623666221130142517 crossref_primary_10_1016_j_biopha_2021_112162 crossref_primary_10_1016_j_carbpol_2021_118011 crossref_primary_10_1128_mSystems_00453_20 crossref_primary_10_1002_wrna_70000 crossref_primary_10_3389_fphar_2020_00791 crossref_primary_10_1128_AAC_01508_20 crossref_primary_10_3389_fmed_2021_604087 crossref_primary_10_1136_postgradmedj_2020_138577 crossref_primary_10_1074_jbc_H120_013397 crossref_primary_10_3390_biomedicines10020437 crossref_primary_10_1016_j_jmgm_2020_107730 crossref_primary_10_1080_17460441_2023_2192921 crossref_primary_10_1016_j_algal_2021_102331 crossref_primary_10_29121_granthaalayah_v9_i3_2021_3769 crossref_primary_10_1021_acssynbio_2c00359 crossref_primary_10_1002_cpt_2176 crossref_primary_10_1097_PR9_0000000000000885 crossref_primary_10_1021_acsinfecdis_0c00236 crossref_primary_10_3390_molecules26123526 crossref_primary_10_3389_fimmu_2020_569760 crossref_primary_10_1002_jmv_25966 crossref_primary_10_1002_phar_2403 crossref_primary_10_1111_cbdd_13812 crossref_primary_10_15690_vsp_v19i2_2105 crossref_primary_10_1080_07391102_2021_1871956 crossref_primary_10_1128_mSystems_00233_21 crossref_primary_10_1111_apt_16894 crossref_primary_10_3390_life11080734 crossref_primary_10_1007_s12291_020_00919_0 crossref_primary_10_3389_fmolb_2020_618318 crossref_primary_10_1016_j_ijbiomac_2020_05_184 crossref_primary_10_2174_1874467214666210811120635 crossref_primary_10_1128_JVI_00190_21 crossref_primary_10_1080_14728214_2020_1810663 crossref_primary_10_3390_biologics1020007 crossref_primary_10_3390_v13091722 crossref_primary_10_1016_j_celrep_2020_107940 crossref_primary_10_1016_j_ejphar_2020_173326 crossref_primary_10_1016_j_ejphar_2020_173568 crossref_primary_10_1016_j_imu_2020_100484 crossref_primary_10_3389_fgene_2020_581668 crossref_primary_10_1016_j_imu_2020_100486 crossref_primary_10_2174_2211738508999200817163335 crossref_primary_10_2174_1568026620666200710105507 crossref_primary_10_3390_scipharm91010015 crossref_primary_10_1016_j_csbj_2023_09_001 crossref_primary_10_1128_AAC_00483_20 crossref_primary_10_1016_j_ejmech_2020_112527 crossref_primary_10_1016_j_jbc_2024_107514 crossref_primary_10_1111_ajt_15982 crossref_primary_10_1016_j_eng_2020_06_011 crossref_primary_10_1186_s12931_021_01885_8 crossref_primary_10_1002_1873_3468_13806 crossref_primary_10_1016_j_cplett_2022_139638 crossref_primary_10_1016_j_procbio_2020_12_014 crossref_primary_10_1080_10406638_2021_1887299 crossref_primary_10_4103_tcmj_tcmj_100_20 crossref_primary_10_7759_cureus_36247 crossref_primary_10_1002_vjch_202100187 crossref_primary_10_3389_fmicb_2020_01756 crossref_primary_10_1007_s12104_020_09992_1 crossref_primary_10_1016_j_ijpharm_2020_120028 crossref_primary_10_1038_s41467_020_18463_z crossref_primary_10_1016_j_chembiol_2020_05_002 crossref_primary_10_3390_jcm10235473 crossref_primary_10_2147_DDDT_S320320 crossref_primary_10_1016_j_jiph_2021_02_006 crossref_primary_10_3390_v14050961 crossref_primary_10_2174_1385272827666230111161632 crossref_primary_10_1016_j_bmc_2020_115745 crossref_primary_10_1016_j_arabjc_2021_103631 crossref_primary_10_3389_fcell_2020_580202 crossref_primary_10_1515_cclm_2020_0612 crossref_primary_10_1136_bmj_m1610 crossref_primary_10_1186_s40794_020_00107_1 crossref_primary_10_1002_jmv_26055 crossref_primary_10_3390_v12101092 crossref_primary_10_1007_s10557_020_07073_y crossref_primary_10_1093_cid_ciaa1041 crossref_primary_10_1016_j_jviromet_2021_114283 crossref_primary_10_3390_v14050974 crossref_primary_10_1017_S0950268822001078 crossref_primary_10_1016_j_mehy_2021_110754 crossref_primary_10_1016_j_jtcms_2020_05_006 crossref_primary_10_1007_s40495_020_00229_2 crossref_primary_10_1016_j_phymed_2023_155038 crossref_primary_10_1007_s11356_020_12200_1 crossref_primary_10_3390_pharmaceutics15030941 crossref_primary_10_1016_j_sjbs_2020_11_078 crossref_primary_10_3390_biomedicines9080996 crossref_primary_10_2174_1389557521666210412161157 crossref_primary_10_1007_s00285_022_01849_6 crossref_primary_10_3390_ph13080188 crossref_primary_10_3390_ph14060503 crossref_primary_10_1254_fpj_21058 crossref_primary_10_1007_s40495_020_00218_5 crossref_primary_10_31083_j_fbl2704123 crossref_primary_10_12688_f1000research_73999_3 crossref_primary_10_12688_f1000research_73999_2 crossref_primary_10_29254_2077_4214_2021_3_161_14_26 crossref_primary_10_37871_jbres1175 crossref_primary_10_1016_j_scp_2022_100744 crossref_primary_10_1111_cts_12840 crossref_primary_10_1016_j_phymed_2020_153440 crossref_primary_10_1016_j_antiviral_2021_105120 crossref_primary_10_14233_ajchem_2022_23858 crossref_primary_10_1074_jbc_AC120_015720 crossref_primary_10_1134_S0036024423030299 crossref_primary_10_1016_j_antiviral_2024_106034 crossref_primary_10_12688_f1000research_73999_1 crossref_primary_10_1016_j_idm_2024_05_004 crossref_primary_10_1016_j_drudis_2020_10_018 crossref_primary_10_1038_s41467_020_20542_0 crossref_primary_10_1055_s_0040_1721190 crossref_primary_10_1038_s41392_022_00907_1 crossref_primary_10_1039_D0MO00057D crossref_primary_10_3390_ph13070155 crossref_primary_10_1038_s41409_020_0919_0 crossref_primary_10_1016_j_antiviral_2023_105716 crossref_primary_10_1016_j_fmre_2021_01_013 crossref_primary_10_5005_jp_journals_10054_0160 crossref_primary_10_13105_wjma_v9_i1_74 crossref_primary_10_3389_fpubh_2020_00281 crossref_primary_10_3389_fphar_2021_630834 crossref_primary_10_2174_2211352519666210217100423 crossref_primary_10_1371_journal_pone_0257965 crossref_primary_10_1007_s41061_020_00318_2 crossref_primary_10_1016_j_biopha_2021_111232 crossref_primary_10_2174_1389557522666220511125102 crossref_primary_10_1016_j_ijpx_2021_100073 crossref_primary_10_3390_v14050928 crossref_primary_10_1007_s12272_021_01331_9 crossref_primary_10_30699_jambs_30_139_75 crossref_primary_10_1074_jbc_REV120_013746 crossref_primary_10_1007_s42250_020_00203_x crossref_primary_10_1007_s11356_021_16096_3 crossref_primary_10_3390_medicina56080386 crossref_primary_10_1098_rsos_210082 crossref_primary_10_1038_s41598_023_42704_y crossref_primary_10_1021_acsptsci_0c00131 crossref_primary_10_1038_s41598_020_73641_9 crossref_primary_10_1080_21505594_2021_1871823 crossref_primary_10_1093_ofid_ofaa105 crossref_primary_10_5114_bta_2022_113915 crossref_primary_10_1177_2472555220958385 crossref_primary_10_7554_eLife_70968 crossref_primary_10_3389_fphar_2020_01258 crossref_primary_10_1016_j_compbiomed_2022_105575 crossref_primary_10_3389_fmed_2021_651658 crossref_primary_10_4155_fmc_2020_0380 crossref_primary_10_1016_j_ejps_2020_105522 crossref_primary_10_1038_s41586_022_05664_3 crossref_primary_10_1016_j_intimp_2021_108232 crossref_primary_10_1089_vim_2020_0102 crossref_primary_10_1016_j_dcmed_2020_12_003 crossref_primary_10_1177_0897190021997001 crossref_primary_10_1016_j_toxlet_2021_07_015 crossref_primary_10_1177_20499361251314763 crossref_primary_10_1038_s41580_021_00432_z crossref_primary_10_2174_0115680266296095240529114058 crossref_primary_10_3389_fphar_2020_590598 crossref_primary_10_1007_s11356_021_16809_8 crossref_primary_10_1111_cts_12815 crossref_primary_10_1002_jcp_30032 crossref_primary_10_32947_ajps_v23i3_1040 crossref_primary_10_1016_j_apsb_2020_06_002 crossref_primary_10_1080_07391102_2020_1794971 crossref_primary_10_1152_ajplung_00355_2020 crossref_primary_10_37503_jbb_2021_9_9 crossref_primary_10_1002_jat_4336 crossref_primary_10_1007_s42535_022_00404_4 crossref_primary_10_1080_13543784_2021_1847270 crossref_primary_10_1134_S1019331622040256 crossref_primary_10_1016_j_molstruc_2020_128823 crossref_primary_10_1186_s44149_021_00017_5 crossref_primary_10_1038_s41392_021_00568_6 crossref_primary_10_1016_j_jcrc_2020_04_004 crossref_primary_10_1021_acs_jcim_2c01002 crossref_primary_10_1039_D0CS01065K crossref_primary_10_1093_nar_gkab370 crossref_primary_10_7759_cureus_10378 crossref_primary_10_1016_j_gendis_2020_06_007 crossref_primary_10_1016_j_biopha_2021_112517 crossref_primary_10_1186_s12951_020_00685_4 crossref_primary_10_2174_1389557521666201222145842 crossref_primary_10_1515_dmdi_2020_0173 crossref_primary_10_1016_j_biopha_2020_111035 crossref_primary_10_1080_10406638_2023_2245103 crossref_primary_10_3390_ijerph17218155 crossref_primary_10_1128_aac_00969_24 crossref_primary_10_1186_s12575_020_00141_5 crossref_primary_10_1002_rmv_2133 crossref_primary_10_1016_j_coviro_2021_03_010 crossref_primary_10_30895_2312_7821_2021_9_4_191_199 crossref_primary_10_1007_s11030_020_10167_2 crossref_primary_10_2217_fvl_2020_0124 crossref_primary_10_3389_fonc_2021_664794 crossref_primary_10_1016_j_virol_2020_07_015 crossref_primary_10_21518_2079_701X_2022_16_15_152_160 crossref_primary_10_1080_10406638_2021_1956552 crossref_primary_10_3390_v12050486 crossref_primary_10_3390_molecules27134212 crossref_primary_10_1007_s00203_021_02183_z crossref_primary_10_1016_j_clim_2020_108448 crossref_primary_10_3389_fmicb_2024_1450060 crossref_primary_10_1016_j_jbc_2022_102169 crossref_primary_10_1134_S0026893321040105 crossref_primary_10_15789_1563_0625_CTF_2095 crossref_primary_10_5799_jmid_790198 crossref_primary_10_1073_pnas_2012294117 crossref_primary_10_15406_jhvrv_2022_09_00250 crossref_primary_10_3389_fddsv_2023_1176768 crossref_primary_10_1002_prp2_705 crossref_primary_10_1128_CMR_00162_20 crossref_primary_10_3389_fmicb_2023_1291761 crossref_primary_10_1007_s11655_021_3512_5 crossref_primary_10_1016_j_cellin_2022_100046 crossref_primary_10_1177_2472555220942123 crossref_primary_10_3390_pharmaceutics12111002 crossref_primary_10_3389_fmolb_2021_645216 crossref_primary_10_2217_pme_2021_0077 crossref_primary_10_1007_s11897_024_00677_7 crossref_primary_10_35366_94636 crossref_primary_10_1161_CIRCULATIONAHA_120_046941 crossref_primary_10_2174_1871526522666220218115617 crossref_primary_10_2174_2589977513666210611155426 crossref_primary_10_3390_molecules28062616 crossref_primary_10_1080_07391102_2020_1767691 crossref_primary_10_1093_cid_ciab698 crossref_primary_10_1080_07391102_2020_1767210 crossref_primary_10_3390_cells9051267 crossref_primary_10_4254_wjh_v13_i12_1850 crossref_primary_10_1016_j_crwh_2020_e00221 crossref_primary_10_1074_jbc_RA120_013679 crossref_primary_10_2478_acph_2022_0014 crossref_primary_10_1007_s40279_020_01288_7 crossref_primary_10_1128_mbio_01060_23 crossref_primary_10_5005_jp_journals_10081_1295 crossref_primary_10_1177_13596535221082773 crossref_primary_10_1002_phar_2398 crossref_primary_10_2217_fvl_2020_0392 crossref_primary_10_1186_s41231_021_00097_y crossref_primary_10_1080_07391102_2021_1940281 crossref_primary_10_1099_jgv_0_001453 crossref_primary_10_2174_2666796701999201209144207 crossref_primary_10_2174_1568026620666200922112300 crossref_primary_10_5005_jp_journals_10071_23491 crossref_primary_10_1007_s41061_023_00432_x crossref_primary_10_1007_s00204_022_03306_1 crossref_primary_10_1002_bmc_5965 crossref_primary_10_1002_adbi_202300511 crossref_primary_10_1016_j_antiviral_2021_105081 crossref_primary_10_1021_acsptsci_2c00045 crossref_primary_10_17116_profmed20222508198 crossref_primary_10_3389_fphar_2020_01091 crossref_primary_10_1021_acs_jmedchem_2c01229 crossref_primary_10_2217_fvl_2021_0160 crossref_primary_10_1155_2023_3892370 crossref_primary_10_1515_dmpt_2020_0173 crossref_primary_10_1038_s41594_021_00651_0 crossref_primary_10_1007_s40267_020_00791_1 crossref_primary_10_5694_mja2_50673 crossref_primary_10_2174_1574888X16666201221151853 crossref_primary_10_1007_s00705_020_04768_3 crossref_primary_10_3390_ijerph17082690 crossref_primary_10_1042_BCJ20200514 crossref_primary_10_1128_aac_00856_24 crossref_primary_10_1016_j_critrevonc_2020_102982 crossref_primary_10_1016_j_ijantimicag_2020_106208 crossref_primary_10_2174_1381612828666220729093340 crossref_primary_10_1016_j_coviro_2021_04_014 crossref_primary_10_3390_transplantology2020022 crossref_primary_10_1002_rmv_2174 crossref_primary_10_1007_s40265_020_01378_w crossref_primary_10_1093_nar_gkab1279 crossref_primary_10_1002_jmv_26254 crossref_primary_10_1016_j_gendis_2020_07_001 crossref_primary_10_1002_pro_3909 crossref_primary_10_30895_2221_996X_2024_569 crossref_primary_10_1016_j_apsb_2021_06_016 crossref_primary_10_1021_acs_jmedchem_0c01140 crossref_primary_10_22207_JPAM_14_SPL1_29 crossref_primary_10_1016_j_jddst_2024_106196 crossref_primary_10_3390_ijms222312638 crossref_primary_10_4103_ajim_ajim_3_21 crossref_primary_10_1002_med_21776 crossref_primary_10_1021_acs_jcim_0c01320 crossref_primary_10_1126_scitranslmed_abo0718 crossref_primary_10_1016_j_jconrel_2025_01_044 crossref_primary_10_1021_acs_biochem_0c00591 crossref_primary_10_1371_journal_pone_0278963 crossref_primary_10_1021_acsinfecdis_3c00311 crossref_primary_10_2147_RRTM_S274673 crossref_primary_10_3389_fchem_2023_1163486 crossref_primary_10_3389_fphar_2021_660710 crossref_primary_10_3390_su13020599 crossref_primary_10_1177_20420986211042517 crossref_primary_10_1208_s12248_020_00532_2 crossref_primary_10_1111_resp_14106 crossref_primary_10_1002_jctb_6641 crossref_primary_10_1055_s_0040_1707386 crossref_primary_10_1080_07391102_2021_1930162 crossref_primary_10_1002_hlca_202200157 crossref_primary_10_1128_aac_00956_23 crossref_primary_10_1016_j_isci_2025_112140 crossref_primary_10_22207_JPAM_14_SPL1_36 crossref_primary_10_1007_s11033_021_06903_y crossref_primary_10_1074_jbc_REV120_013930 crossref_primary_10_1021_acsmedchemlett_0c00316 crossref_primary_10_3389_fmed_2020_572485 crossref_primary_10_1016_j_arcmed_2020_09_010 crossref_primary_10_1039_D0NJ02656E crossref_primary_10_2217_fvl_2021_0048 crossref_primary_10_3390_scipharm88020029 crossref_primary_10_3390_jcm10010156 crossref_primary_10_1007_s13205_021_02657_3 crossref_primary_10_1038_s41598_022_13585_4 crossref_primary_10_1080_08830185_2020_1871477 crossref_primary_10_1002_mds3_10140 crossref_primary_10_1002_phar_2429 crossref_primary_10_1016_j_heliyon_2020_e04743 crossref_primary_10_1111_bjh_16597 crossref_primary_10_15252_emmm_202013105 crossref_primary_10_3390_biomedicines11102619 crossref_primary_10_1016_j_antiviral_2020_104787 crossref_primary_10_1055_a_2332_3253 crossref_primary_10_1080_08998280_2021_1885289 crossref_primary_10_1007_s40262_021_00984_5 crossref_primary_10_1016_j_prrv_2020_05_001 crossref_primary_10_1097_FJC_0000000000000836 crossref_primary_10_1016_j_jbc_2022_101923 crossref_primary_10_1093_jac_dkaa321 crossref_primary_10_1016_j_jiph_2023_02_009 crossref_primary_10_1016_j_jbc_2021_101529 crossref_primary_10_12688_f1000research_23829_2 crossref_primary_10_12688_f1000research_23829_1 crossref_primary_10_1016_j_bcp_2021_114800 crossref_primary_10_1073_pnas_2007346117 crossref_primary_10_1007_s10557_020_07024_7 crossref_primary_10_3390_ijms232012649 crossref_primary_10_1002_psp4_12736 crossref_primary_10_1038_s41598_023_33572_7 crossref_primary_10_2174_2210315512666220613101120 crossref_primary_10_1016_j_prp_2020_153222 crossref_primary_10_1016_j_biopha_2022_114037 crossref_primary_10_2174_2666796701999200617155629 crossref_primary_10_1080_07391102_2021_1890223 crossref_primary_10_1155_2020_7527953 crossref_primary_10_2147_DDDT_S261154 crossref_primary_10_1016_j_ajogmf_2020_100159 crossref_primary_10_1177_09720634221109295 crossref_primary_10_3390_nano10091645 crossref_primary_10_3390_ijms222011143 crossref_primary_10_1016_j_heliyon_2023_e13285 crossref_primary_10_3390_bios12110950 crossref_primary_10_1109_TMI_2022_3178523 crossref_primary_10_1111_hepr_13510 crossref_primary_10_3390_ijerph18041626 crossref_primary_10_1007_s44231_022_00021_4 crossref_primary_10_1556_2066_2020_00009 crossref_primary_10_1016_j_ajps_2021_09_002 crossref_primary_10_1016_j_jbc_2021_100770 crossref_primary_10_2174_011573398X248003231106092908 crossref_primary_10_1016_j_bcp_2022_115279 crossref_primary_10_3389_fimmu_2020_616595 crossref_primary_10_1002_prp2_674 crossref_primary_10_1093_nar_gkae153 crossref_primary_10_3390_biomedicines8050109 crossref_primary_10_3390_su12093603 crossref_primary_10_1021_acs_jcim_0c00821 crossref_primary_10_1186_s43556_020_00017_w crossref_primary_10_1016_j_jmii_2020_09_002 crossref_primary_10_1186_s12929_022_00852_9 crossref_primary_10_1016_j_bj_2021_11_010 crossref_primary_10_1016_j_antiviral_2020_104899 crossref_primary_10_3390_biophysica4020009 crossref_primary_10_1016_j_jmgm_2021_107851 crossref_primary_10_15789_2220_7619_CEC_1473 crossref_primary_10_1039_D1CP04159B crossref_primary_10_3390_ijms21082839 crossref_primary_10_1021_acscentsci_0c00489 crossref_primary_10_1016_j_scitotenv_2020_138914 crossref_primary_10_1016_j_rmcr_2020_101319 crossref_primary_10_1111_fcp_12889 crossref_primary_10_2174_1568026620999200517043137 crossref_primary_10_15252_emmm_202013426 crossref_primary_10_3390_jcm9113777 crossref_primary_10_1016_j_arabjc_2021_103385 crossref_primary_10_1002_cem_3548 crossref_primary_10_1183_13993003_01727_2020 crossref_primary_10_3390_jcm9093045 crossref_primary_10_1016_j_jiph_2020_11_009 crossref_primary_10_1126_sciadv_abf1004 crossref_primary_10_1002_jmv_27730 crossref_primary_10_1016_j_onehlt_2020_100128 crossref_primary_10_1007_s43440_020_00155_6 crossref_primary_10_1038_s41586_020_2368_8 crossref_primary_10_1111_tbed_13734 crossref_primary_10_3390_jcm9082399 crossref_primary_10_1016_j_virusres_2024_199356 crossref_primary_10_1021_acs_jpclett_2c00087 crossref_primary_10_1007_s40121_020_00318_1 crossref_primary_10_4103_jdmimsu_jdmimsu_45_22 crossref_primary_10_29328_journal_ijcv_1001013 crossref_primary_10_1016_j_ejphar_2020_173620 crossref_primary_10_12998_wjcc_v8_i18_3920 crossref_primary_10_1016_j_biopha_2020_110668 crossref_primary_10_1016_j_molstruc_2021_131756 crossref_primary_10_1093_bib_bbab045 crossref_primary_10_3390_jcm9051473 crossref_primary_10_3390_molecules27092918 crossref_primary_10_1080_07391102_2021_1872419 crossref_primary_10_1016_j_ab_2021_114118 crossref_primary_10_1016_j_jacbts_2020_04_002 crossref_primary_10_1186_s13613_020_00661_z crossref_primary_10_1002_cmdc_202300661 crossref_primary_10_1016_j_drup_2020_100721 crossref_primary_10_1007_s10930_020_09933_w crossref_primary_10_1016_j_ijbiomac_2021_01_076 crossref_primary_10_3389_fmicb_2020_02098 crossref_primary_10_18678_dtfd_890089 crossref_primary_10_2147_IJN_S315705 crossref_primary_10_5937_PsihDan2001089M crossref_primary_10_5005_jp_journals_10055_0107 crossref_primary_10_1186_s13020_021_00461_y crossref_primary_10_2478_pjph_2020_0014 crossref_primary_10_4155_fdd_2020_0010 crossref_primary_10_1186_s12879_020_05507_4 crossref_primary_10_2174_0929867327666200903115138 crossref_primary_10_3390_ijms23169453 crossref_primary_10_33483_jfpau_1073079 crossref_primary_10_1016_j_jfma_2021_04_026 crossref_primary_10_1128_jvi_00671_22 crossref_primary_10_5812_pedinfect_104266 crossref_primary_10_1007_s00018_020_03580_1 crossref_primary_10_4103_bbrj_bbrj_14_21 crossref_primary_10_1016_j_antiviral_2020_104857 crossref_primary_10_3389_fphar_2020_585331 crossref_primary_10_1039_D0CP05948J crossref_primary_10_1021_acs_biochem_1c00292 crossref_primary_10_1080_07391102_2020_1834457 crossref_primary_10_3346_jkms_2021_36_e298 crossref_primary_10_1039_D0RA04743K crossref_primary_10_12688_wellcomeopenres_15936_1 crossref_primary_10_1016_j_checat_2022_03_019 crossref_primary_10_1080_10255842_2020_1863380 crossref_primary_10_15212_bioi_2024_0055 crossref_primary_10_3390_immuno1010004 crossref_primary_10_1002_ejoc_202000831 crossref_primary_10_1080_2314808X_2020_1843119 crossref_primary_10_1371_journal_pone_0240524 crossref_primary_10_1016_j_bioorg_2020_104269 crossref_primary_10_1016_j_jddst_2023_104567 |
| Cites_doi | 10.1073/pnas.1718806115 10.1038/s41467-019-13940-6 10.1371/journal.ppat.1002980 10.1073/pnas.1323705111 10.1038/s41467-019-10280-3 10.1126/scitranslmed.aal3653 10.3390/v11040326 10.1038/srep43395 10.1128/mBio.00221-18 10.1002/0471140864.ps0520s51 10.1002/j.1460-2075.1989.tb08565.x 10.1038/nbt1036 10.1371/journal.ppat.1006889 10.1074/jbc.M806797200 10.1186/s13063-019-3846-x 10.1128/AAC.03011-14 10.1016/j.celrep.2017.10.005 10.1038/s41598-018-22328-3 10.1021/acs.jmedchem.6b01594 10.1038/sj.emboj.7601368 10.1038/nature17180 10.1371/journal.ppat.1004995 10.1128/JVI.73.3.2333-2342.1999 10.1056/NEJMoa1910993 10.1016/j.antiviral.2019.104541 |
| ContentType | Journal Article |
| Copyright | 2020 © 2020 Gordon et al. 2020 Gordon et al. 2020 Gordon et al. 2020 Gordon et al. |
| Copyright_xml | – notice: 2020 © 2020 Gordon et al. – notice: 2020 Gordon et al. – notice: 2020 Gordon et al. 2020 Gordon et al. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1074/jbc.AC120.013056 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| DocumentTitleAlternate | EDITORS' PICK: Coronavirus polymerase inhibition with remdesivir |
| EISSN | 1083-351X |
| EndPage | 4779 |
| ExternalDocumentID | PMC7152756 32094225 10_1074_jbc_AC120_013056 S0021925817485747 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: CIHR grantid: 159507 – fundername: ; grantid: 159507 – fundername: Alberta Ministry of Economic Development, Trade, and Tourism by the Major Innovation Fund Program grantid: AMR-One Health Consortium |
| GroupedDBID | --- -DZ -ET -~X 0SF 18M 29J 2WC 34G 39C 4.4 53G 5BI 5GY 5RE 5VS 6I. 79B 85S AAEDW AAFTH AAFWJ AARDX AAXUO ABDNZ ABOCM ABPPZ ABRJW ACGFO ACNCT ACSFO ADBBV ADIYS ADNWM AENEX AEXQZ AFOSN AFPKN ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW CJ0 CS3 DIK DU5 E3Z EBS EJD F5P FDB FRP GROUPED_DOAJ GX1 HH5 HYE IH2 KQ8 L7B N9A OK1 P0W P2P R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UKR UPT VQA W8F WH7 WOQ XSW YQT YSK YWH YZZ ZA5 ~02 ~KM .55 .7T .GJ 0R~ 186 3O- 41~ 6TJ AALRI AAYJJ AAYOK AAYWO AAYXX ABFSI ACVFH ACYGS ADCNI ADVLN ADXHL AEUPX AFFNX AFPUW AI. AIGII AITUG AKBMS AKRWK AKYEP C1A CITATION E.L FA8 H13 J5H MVM NHB OHT P-O QZG UQL VH1 WHG X7M XJT Y6R YYP ZE2 ZGI ZY4 CGR CUY CVF ECM EIF NPM Z5M 7X8 5PM |
| ID | FETCH-LOGICAL-c443t-df7204e4e820e4722be9605c90f6fe44c1a7b8f5379be3bda3203f69effc28123 |
| ISSN | 0021-9258 1083-351X |
| IngestDate | Thu Aug 21 14:37:28 EDT 2025 Fri Jul 11 09:12:33 EDT 2025 Wed Feb 19 02:29:50 EST 2025 Tue Jul 01 04:11:52 EDT 2025 Thu Apr 24 23:05:49 EDT 2025 Fri Feb 23 02:45:06 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 15 |
| Keywords | Ebola virus (EBOV) positive-sense RNA virus Middle East respiratory syndrome coronavirus (MERS–CoV) drug development coronavirus RNA chain termination remdesivir viral replicase RNA-dependent RNA polymerase (RdRp) SARS–CoV-2 viral polymerase enzyme inhibitor nucleoside/nucleotide analog antiviral drug plus-stranded RNA virus |
| Language | English |
| License | This is an open access article under the CC BY license. 2020 Gordon et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c443t-df7204e4e820e4722be9605c90f6fe44c1a7b8f5379be3bda3203f69effc28123 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Craig E. Cameron These authors contributed equally to this work. |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7152756 |
| PMID | 32094225 |
| PQID | 2364032988 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7152756 proquest_miscellaneous_2364032988 pubmed_primary_32094225 crossref_citationtrail_10_1074_jbc_AC120_013056 crossref_primary_10_1074_jbc_AC120_013056 elsevier_sciencedirect_doi_10_1074_jbc_AC120_013056 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-04-10 |
| PublicationDateYYYYMMDD | 2020-04-10 |
| PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-10 day: 10 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A |
| PublicationTitle | The Journal of biological chemistry |
| PublicationTitleAlternate | J Biol Chem |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc American Society for Biochemistry and Molecular Biology |
| Publisher_xml | – name: Elsevier Inc – name: American Society for Biochemistry and Molecular Biology |
| References | Siegel, Hui, Doerffler, Clarke, Chun, Zhang, Neville, Carra, Lew, Ross, Wang, Wolfe, Jordan, Soloveva, Knox (bib2) 2017; 60 Noton, Deflubé, Tremaglio, Fearns (bib12) 2012; 8 Kirchdoerfer, Ward (bib13) 2019; 10 Subissi, Posthuma, Collet, Zevenhoven-Dobbe, Gorbalenya, Decroly, Snijder, Canard, Imbert (bib15) 2014; 111 Bieniossek, Richmond, Berger (bib26) 2008 Berger, Fitzgerald, Richmond (bib25) 2004; 22 Warren, Jordan, Lo, Ray, Mackman, Soloveva, Siegel, Perron, Bannister, Hui, Larson, Strickley, Wells, Stuthman, Van Tongeren (bib4) 2016; 531 Deval, Hong, Wang, Taylor, Smith, Fung, Stevens, Liu, Jin, Dyatkina, Prhavc, Stoycheva, Serebryany, Liu, Smith (bib11) 2015; 11 Arabi, Asiri, Assiri, Aziz Jokhdar, Alothman, Balkhy, AlJohani, Al Harbi, Kojan, Al Jeraisy, Deeb, Memish, Ghazal, Al Faraj, Al-Hameed (bib22) 2020; 21 Tchesnokov, Raeisimakiani, Ngure, Marchant, Götte (bib10) 2018; 8 Agostini, Andres, Sims, Graham, Sheahan, Lu, Smith, Case, Feng, Jordan, Ray, Cihlar, Siegel, Mackman, Clarke (bib5) 2018; 9 de Wilde, Jochmans, Posthuma, Zevenhoven-Dobbe, van Nieuwkoop, Bestebroer, van den Hoogen, Neyts, Snijder (bib21) 2014; 58 Poch, Sauvaget, Delarue, Tordo (bib16) 1989; 8 Sheahan, Sims, Graham, Menachery, Gralinski, Case, Leist, Pyrc, Feng, Trantcheva, Bannister, Park, Babusis, Clarke, Mackman (bib19) 2017; 9 Sheahan, Sims, Leist, Schäfer, Won, Brown, Montgomery, Hogg, Babusis, Clarke, Spahn, Bauer, Sellers, Porter, Feng (bib1) 2020; 11 Mühlberger, Weik, Volchkov, Klenk, Becker (bib9) 1999; 73 Mulangu, Dodd, Davey, Tshiani Mbaya, Proschan, Mukadi, Lusakibanza Manzo, Nzolo, Tshomba Oloma, Ibanda, Ali, Coulibaly, Levine, Grais, Diaz (bib18) 2019; 381 Tchesnokov, Obikhod, Schinazi, Götte (bib23) 2008; 283 Imbert, Guillemot, Bourhis, Bussetta, Coutard, Egloff, Ferron, Gorbalenya, Canard (bib17) 2006; 25 Ferron, Subissi, Silveira De Morais, Le, Sevajol, Gluais, Decroly, Vonrhein, Bricogne, Canard, Imbert (bib14) 2018; 115 Jordan, Liu, Raynaud, Lo, Spiropoulou, Symons, Beigelman, Deval (bib7) 2018; 14 Lo, Jordan, Arvey, Sudhamsu, Shrivastava-Ranjan, Hotard, Flint, McMullan, Siegel, Clarke, Mackman, Hui, Perron, Ray, Cihlar (bib3) 2017; 7 Dulin, Arnold, van Laar, Oh, Lee, Perkins, Harki, Depken, Cameron, Dekker (bib24) 2017; 21 Brown, Won, Graham, Dinnon, Sims, Feng, Cihlar, Denison, Baric, Sheahan (bib6) 2019; 169 de Wit, Feldmann, Cronin, Jordan, Okumura, Thomas, Scott, Cihlar, Feldmann (bib20) 2020 Tchesnokov, Feng, Porter, Götte (bib8) 2019; 11 Lo (10.1074/jbc.AC120.013056_bib3) 2017; 7 Tchesnokov (10.1074/jbc.AC120.013056_bib8) 2019; 11 Imbert (10.1074/jbc.AC120.013056_bib17) 2006; 25 Deval (10.1074/jbc.AC120.013056_bib11) 2015; 11 Poch (10.1074/jbc.AC120.013056_bib16) 1989; 8 de Wilde (10.1074/jbc.AC120.013056_bib21) 2014; 58 Mulangu (10.1074/jbc.AC120.013056_bib18) 2019; 381 Brown (10.1074/jbc.AC120.013056_bib6) 2019; 169 Sheahan (10.1074/jbc.AC120.013056_bib1) 2020; 11 Ferron (10.1074/jbc.AC120.013056_bib14) 2018; 115 Noton (10.1074/jbc.AC120.013056_bib12) 2012; 8 Arabi (10.1074/jbc.AC120.013056_bib22) 2020; 21 Agostini (10.1074/jbc.AC120.013056_bib5) 2018; 9 Bieniossek (10.1074/jbc.AC120.013056_bib26) 2008 Sheahan (10.1074/jbc.AC120.013056_bib19) 2017; 9 Jordan (10.1074/jbc.AC120.013056_bib7) 2018; 14 Warren (10.1074/jbc.AC120.013056_bib4) 2016; 531 Subissi (10.1074/jbc.AC120.013056_bib15) 2014; 111 Tchesnokov (10.1074/jbc.AC120.013056_bib23) 2008; 283 Berger (10.1074/jbc.AC120.013056_bib25) 2004; 22 de Wit (10.1074/jbc.AC120.013056_bib20) 2020 Mühlberger (10.1074/jbc.AC120.013056_bib9) 1999; 73 Tchesnokov (10.1074/jbc.AC120.013056_bib10) 2018; 8 Dulin (10.1074/jbc.AC120.013056_bib24) 2017; 21 Siegel (10.1074/jbc.AC120.013056_bib2) 2017; 60 Kirchdoerfer (10.1074/jbc.AC120.013056_bib13) 2019; 10 |
| References_xml | – volume: 169 start-page: 104541 year: 2019 ident: bib6 article-title: Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase publication-title: Antiviral Res – volume: 11 year: 2015 ident: bib11 article-title: Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2′-fluoro-4′-chloromethyl-cytidine triphosphate publication-title: PLoS Pathog – volume: 9 start-page: e00221 year: 2018 end-page: 18 ident: bib5 article-title: Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease publication-title: mBio – volume: 283 start-page: 34218 year: 2008 end-page: 34228 ident: bib23 article-title: Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase publication-title: J. Biol. Chem – volume: 21 start-page: 1063 year: 2017 end-page: 1076 ident: bib24 article-title: Signatures of nucleotide analog incorporation by an RNA-dependent RNA polymerase revealed using high-throughput magnetic tweezers publication-title: Cell Reports – volume: 22 start-page: 1583 year: 2004 end-page: 1587 ident: bib25 article-title: Baculovirus expression system for heterologous multiprotein complexes publication-title: Nat. Biotechnol – volume: 111 start-page: E3900 year: 2014 end-page: E3909 ident: bib15 article-title: One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 14 start-page: e1006889 year: 2018 ident: bib7 article-title: Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase publication-title: PLoS Pathog – volume: 11 start-page: 222 year: 2020 ident: bib1 article-title: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon β against MERS–CoV publication-title: Nat. Commun – volume: 58 start-page: 4875 year: 2014 end-page: 4884 ident: bib21 article-title: Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture publication-title: Antimicrob. Agents Chemother – volume: 60 start-page: 1648 year: 2017 end-page: 1661 ident: bib2 article-title: Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses publication-title: J. Med. Chem – volume: 25 start-page: 4933 year: 2006 end-page: 4942 ident: bib17 article-title: A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus publication-title: EMBO J – volume: 115 start-page: E162 year: 2018 end-page: E171 ident: bib14 article-title: Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 531 start-page: 381 year: 2016 end-page: 385 ident: bib4 article-title: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys publication-title: Nature – volume: 9 start-page: eaal3653 year: 2017 ident: bib19 article-title: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses publication-title: Sci. Transl. Med – volume: 21 start-page: 8 year: 2020 ident: bib22 article-title: Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial publication-title: Trials – volume: 73 start-page: 2333 year: 1999 end-page: 2342 ident: bib9 article-title: Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems publication-title: J. Virol – volume: 8 start-page: 3867 year: 1989 end-page: 3874 ident: bib16 article-title: Identification of four conserved motifs among the RNA-dependent polymerase encoding elements publication-title: EMBO J – volume: 8 start-page: e1002980 year: 2012 ident: bib12 article-title: The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter publication-title: PLoS Pathog – volume: 10 start-page: 2342 year: 2019 ident: bib13 article-title: Structure of the SARS–CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors publication-title: Nat. Commun – year: 2008 ident: bib26 article-title: MultiBac: multigene baculovirus-based eukaryotic protein complex production publication-title: Curr. Protoc. Protein Sci – volume: 11 start-page: E326 year: 2019 ident: bib8 article-title: Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir publication-title: Viruses – volume: 7 start-page: 43395 year: 2017 ident: bib3 article-title: GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses publication-title: Sci. Rep – start-page: 201922083 year: 2020 ident: bib20 article-title: Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS–CoV infection publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 8 start-page: 3970 year: 2018 ident: bib10 article-title: Recombinant RNA-dependent RNA polymerase complex of Ebola virus publication-title: Sci. Rep – volume: 381 start-page: 2293 year: 2019 end-page: 2303 ident: bib18 article-title: A randomized, controlled trial of Ebola virus disease therapeutics publication-title: New Engl. J. Med – volume: 115 start-page: E162 year: 2018 ident: 10.1074/jbc.AC120.013056_bib14 article-title: Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.1718806115 – volume: 11 start-page: 222 year: 2020 ident: 10.1074/jbc.AC120.013056_bib1 article-title: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon β against MERS–CoV publication-title: Nat. Commun doi: 10.1038/s41467-019-13940-6 – volume: 8 start-page: e1002980 year: 2012 ident: 10.1074/jbc.AC120.013056_bib12 article-title: The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002980 – volume: 111 start-page: E3900 year: 2014 ident: 10.1074/jbc.AC120.013056_bib15 article-title: One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.1323705111 – volume: 10 start-page: 2342 year: 2019 ident: 10.1074/jbc.AC120.013056_bib13 article-title: Structure of the SARS–CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors publication-title: Nat. Commun doi: 10.1038/s41467-019-10280-3 – volume: 9 start-page: eaal3653 year: 2017 ident: 10.1074/jbc.AC120.013056_bib19 article-title: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses publication-title: Sci. Transl. Med doi: 10.1126/scitranslmed.aal3653 – volume: 11 start-page: E326 year: 2019 ident: 10.1074/jbc.AC120.013056_bib8 article-title: Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir publication-title: Viruses doi: 10.3390/v11040326 – volume: 7 start-page: 43395 year: 2017 ident: 10.1074/jbc.AC120.013056_bib3 article-title: GS-5734 and its parent nucleoside analog inhibit filo-, pneumo-, and paramyxoviruses publication-title: Sci. Rep doi: 10.1038/srep43395 – volume: 9 start-page: e00221 year: 2018 ident: 10.1074/jbc.AC120.013056_bib5 article-title: Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease publication-title: mBio doi: 10.1128/mBio.00221-18 – year: 2008 ident: 10.1074/jbc.AC120.013056_bib26 article-title: MultiBac: multigene baculovirus-based eukaryotic protein complex production publication-title: Curr. Protoc. Protein Sci doi: 10.1002/0471140864.ps0520s51 – volume: 8 start-page: 3867 year: 1989 ident: 10.1074/jbc.AC120.013056_bib16 article-title: Identification of four conserved motifs among the RNA-dependent polymerase encoding elements publication-title: EMBO J doi: 10.1002/j.1460-2075.1989.tb08565.x – volume: 22 start-page: 1583 year: 2004 ident: 10.1074/jbc.AC120.013056_bib25 article-title: Baculovirus expression system for heterologous multiprotein complexes publication-title: Nat. Biotechnol doi: 10.1038/nbt1036 – volume: 14 start-page: e1006889 year: 2018 ident: 10.1074/jbc.AC120.013056_bib7 article-title: Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1006889 – volume: 283 start-page: 34218 year: 2008 ident: 10.1074/jbc.AC120.013056_bib23 article-title: Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase publication-title: J. Biol. Chem doi: 10.1074/jbc.M806797200 – volume: 21 start-page: 8 year: 2020 ident: 10.1074/jbc.AC120.013056_bib22 article-title: Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial publication-title: Trials doi: 10.1186/s13063-019-3846-x – volume: 58 start-page: 4875 year: 2014 ident: 10.1074/jbc.AC120.013056_bib21 article-title: Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture publication-title: Antimicrob. Agents Chemother doi: 10.1128/AAC.03011-14 – volume: 21 start-page: 1063 year: 2017 ident: 10.1074/jbc.AC120.013056_bib24 article-title: Signatures of nucleotide analog incorporation by an RNA-dependent RNA polymerase revealed using high-throughput magnetic tweezers publication-title: Cell Reports doi: 10.1016/j.celrep.2017.10.005 – volume: 8 start-page: 3970 year: 2018 ident: 10.1074/jbc.AC120.013056_bib10 article-title: Recombinant RNA-dependent RNA polymerase complex of Ebola virus publication-title: Sci. Rep doi: 10.1038/s41598-018-22328-3 – volume: 60 start-page: 1648 year: 2017 ident: 10.1074/jbc.AC120.013056_bib2 article-title: Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses publication-title: J. Med. Chem doi: 10.1021/acs.jmedchem.6b01594 – volume: 25 start-page: 4933 year: 2006 ident: 10.1074/jbc.AC120.013056_bib17 article-title: A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus publication-title: EMBO J doi: 10.1038/sj.emboj.7601368 – volume: 531 start-page: 381 year: 2016 ident: 10.1074/jbc.AC120.013056_bib4 article-title: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys publication-title: Nature doi: 10.1038/nature17180 – volume: 11 year: 2015 ident: 10.1074/jbc.AC120.013056_bib11 article-title: Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2′-fluoro-4′-chloromethyl-cytidine triphosphate publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004995 – volume: 73 start-page: 2333 year: 1999 ident: 10.1074/jbc.AC120.013056_bib9 article-title: Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems publication-title: J. Virol doi: 10.1128/JVI.73.3.2333-2342.1999 – start-page: 201922083 year: 2020 ident: 10.1074/jbc.AC120.013056_bib20 article-title: Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS–CoV infection publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 381 start-page: 2293 year: 2019 ident: 10.1074/jbc.AC120.013056_bib18 article-title: A randomized, controlled trial of Ebola virus disease therapeutics publication-title: New Engl. J. Med doi: 10.1056/NEJMoa1910993 – volume: 169 start-page: 104541 year: 2019 ident: 10.1074/jbc.AC120.013056_bib6 article-title: Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase publication-title: Antiviral Res doi: 10.1016/j.antiviral.2019.104541 |
| SSID | ssj0000491 |
| Score | 2.7083304 |
| Snippet | Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing... Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4773 |
| SubjectTerms | Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - chemistry Adenosine Monophosphate - pharmacology Alanine - analogs & derivatives Alanine - chemistry Alanine - pharmacology Animals Antiviral Agents - chemistry Antiviral Agents - pharmacology antiviral drug coronavirus Coronavirus - enzymology drug development Ebola virus (EBOV) Ebolavirus - enzymology Editors' Picks enzyme inhibitor Gene Expression Middle East respiratory syndrome coronavirus (MERS–CoV) Middle East Respiratory Syndrome Coronavirus - enzymology Nucleic Acid Synthesis Inhibitors - chemistry Nucleic Acid Synthesis Inhibitors - pharmacology nucleoside/nucleotide analog plus-stranded RNA virus positive-sense RNA virus remdesivir RNA RNA chain termination RNA-dependent RNA polymerase (RdRp) RNA-Dependent RNA Polymerase - antagonists & inhibitors RNA-Dependent RNA Polymerase - genetics SARS–CoV-2 Sf9 Cells Viral Nonstructural Proteins - genetics viral polymerase viral replicase Virus Replication - drug effects |
| Title | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus |
| URI | https://dx.doi.org/10.1074/jbc.AC120.013056 https://www.ncbi.nlm.nih.gov/pubmed/32094225 https://www.proquest.com/docview/2364032988 https://pubmed.ncbi.nlm.nih.gov/PMC7152756 |
| Volume | 295 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2gWAvCDY-ypeMhJBQlS4fTtI8lmpoGuo00CaVpyhObFZok6pNJ5VH_nLuYjvJyphgL1HjxLGb-8idfXc_Qt7aAXeTLMkszrhtgfaTViTB53GSzOacJeCNYTby6CQ4OmfHY3-8tX23FbW0Knkv_XltXsltqAptQFfMkv0PytYPhQb4DfSFI1AYjv9MY3gzEwzUnVbR4QiS1F2IWSaW2NqdF2ATl1NM7ruYcNwk-HIysAzybYlniNOwxqWppVDJJqNqzaJ7mCxLeFSzE2-KG8BAC7Df4fF60eB7M5uWfavKO6kCJAZVro72AZdXb_cn08tJ3j3u1UsIiOCVFz-Ky0pNfysW3dP6Irx9HUC87n6tWzEaVnGeSpiHyesuejnDxdhSSwe2NhkEqNpaQasfJkU9URV_YqCDNWJnW2tWMSeuqgffE0qrg52JKQvjttp3Fbin4W-_pcVZqOBVtEUAp9G1Xxswv_Brw9PeYOi4dg93gVWZ9BbzzWcV93kuONKuSvLeqPB9OhqGiC7sB9vkjgvuDurrT5-bqvfgxSnkR_3X9HY7DH-wOfguuWdG-pul9acntRkQ3LKwzh6SB5p16EDx-SOyJfI9sj_Igftma_qOVsHKFR32yP2hodQ--QWMR2sxoEYMaCMG1IgBNWJAr4gBntFGDCiKAVViQFEMaEsMqBED2hKDx-T84-HZ8MjS0CJWyphXWplEcCbBBBjAAuulcgGuvJ9GtgykYCx1kpD3pe-FERcezxJ4qZ4MIiFl6oJN7D0hO3mRi2eERlmU2I4EyznxmQwld6UjvMADu9rJuM865MCQIU513X2Ef5nGVfxHyGKgYVzRMFY07JD3dY-5qjlzw72eoWysbWZlC8fApDf0emOYIAZi4R5hkotitYwRT8L23Kjf75CniinqORjG6pDwCrvUN2Cp-qtX8slFVbJe8_fzW_d8QXYbbfGS7JSLlXgF7kDJX1ey8hsnzRK8 |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+antiviral+compound+remdesivir+potently+inhibits+RNA-dependent+RNA+polymerase+from+Middle+East+respiratory+syndrome+coronavirus&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Gordon%2C+Calvin+J.&rft.au=Tchesnokov%2C+Egor+P.&rft.au=Feng%2C+Joy+Y.&rft.au=Porter%2C+Danielle+P.&rft.date=2020-04-10&rft.pub=American+Society+for+Biochemistry+and+Molecular+Biology&rft.issn=0021-9258&rft.eissn=1083-351X&rft.volume=295&rft.issue=15&rft.spage=4773&rft.epage=4779&rft_id=info:doi/10.1074%2Fjbc.AC120.013056&rft_id=info%3Apmid%2F32094225&rft.externalDocID=PMC7152756 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |